<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-046843</identifier>
<setSpec>0212-7199</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Association of adenocarcinoma of esophagus and breast cancer in a male with Madelung´ disease</dc:title>
<dc:description xml:lang="en">The development of a cancer of the esophagus in women who previously had received radiotherapy for breast cancer is a known although infrequent event. The risk of apparition of the second neoplasia is greater in women who survive at least ten years after the exposition to the radiation. Squamous cell carcinoma is the histological subtype more frequent. We report a case of adenocarcinoma of the esophagus in a man diagnosed of benign symmetrical lipomatosis (Madelung&#146; disease), who had received adjuvant radiotherapy three years before for breast cancer</dc:description>
<dc:creator>Ribas Arino, M. T</dc:creator>
<dc:creator>Linares Torres, P</dc:creator>
<dc:creator>Espinel Díez, J</dc:creator>
<dc:creator>Álvarez Posadilla, M</dc:creator>
<dc:creator>Llano Alonso, C</dc:creator>
<dc:creator>Vivas Alegre, S</dc:creator>
<dc:creator>Castañón López, C</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">La aparición de un cáncer de esófago en mujeres que previamente han recibido radioterapia como tratamiento de un cáncer de mama es un hecho conocido aunque poco frecuente. El riesgo de aparición de la segunda neoplasia es mayor cuando han transcurrido diez o más años desde la exposición a la radiación. La estirpe histológica de la neoplasia de esófago más frecuente es la de carcinoma de células escamosas. Se presenta un caso de adenocarcinoma de esófago en un varón, diagnosticado de lipomatosis bilateral simétrica o enfermedad de Madelung, que recibió radioterapia tres años antes por presentar un cáncer de mama</dc:description>
<dc:source>An Med Interna;23(3): 133-135, mar. 2006. ilus</dc:source>
<dc:identifier>ibc-046843</dc:identifier>
<dc:title xml:lang="es">Asociación de adenocarcinoma de esófago y cáncer de mama en un varón con enfermedad de Madelung</dc:title>
<dc:subject>^d238^s22012</dc:subject>
<dc:subject>^d23977^s22027</dc:subject>
<dc:subject>^d23947^s22073</dc:subject>
<dc:subject>^d28612</dc:subject>
<dc:subject>^d31593^s22012</dc:subject>
<dc:subject>^d31593^s22057</dc:subject>
<dc:subject>^d19230^s22012</dc:subject>
<dc:subject>^d31593^s22058</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d31593^s22009</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d20174</dc:subject>
<dc:subject>^d1493^s22012</dc:subject>
<dc:subject>^d32331^s22009</dc:subject>
<dc:subject>^d9575^s22027</dc:subject>
<dc:subject>^d22102^s22020</dc:subject>
<dc:subject>^d32054^s22020</dc:subject>
<dc:subject>^d32331^s22057</dc:subject>
<dc:subject>^d32331^s22012</dc:subject>
<dc:subject>^d31474</dc:subject>
<dc:subject>^d30193</dc:subject>
<dc:subject>^d32331^s22058</dc:subject>
<dc:subject>^d8374</dc:subject>
<dc:type>article</dc:type>
<dc:date>200603</dc:date>
</metadata>
</record>
</ibecs-document>
